|
|
| Phases of Development | Discovery | Preclinical | Phase I | Phase I/II | Phase II | Phase II/III | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 0 | 1 | 0 | 4 | 1 | 1 | 1 | 0 | | Dermatology | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | | Genitourinary | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Inflammation | 1 | 1 | 0 | 1 | 4 | 0 | 1 | 0 | 1 | | Neurology | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | | Pulmonary | 0 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 1 | | Renal | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Phosphodiesterase-4 (PDE-4)